| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/06/2009 | WO2002074782A3 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 08/06/2009 | US20090197812 Peptides for Inhibiting Transglutaminase |
| 08/06/2009 | US20090197809 Antifungal methods |
| 08/06/2009 | US20090197801 Neuritogenic peptides |
| 08/06/2009 | US20090197799 Methods for preparing purified lipotides |
| 08/06/2009 | US20090197315 Fullerene-based amino acids |
| 08/06/2009 | US20090196927 Polypeptide Inhibitors of HSP27 Kinase and Uses Therefor |
| 08/05/2009 | EP2085474A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 08/05/2009 | EP2084275A2 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 08/05/2009 | EP2083843A2 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 08/05/2009 | EP2007911A4 Soluble virus-specific t-cell receptor compositions |
| 08/05/2009 | EP1648934B1 Pharmaceutical composition comprising cyclic somatostatin analogues |
| 08/05/2009 | EP1624884A4 Somatostatin vectors |
| 08/05/2009 | EP1512014B1 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 08/05/2009 | EP1420681A4 Peptide-based multimeric targeted contrast agents |
| 08/05/2009 | EP1282432B1 Use of peptide antagonists of zonulin for prevention or delay of the onset of diabetes |
| 08/05/2009 | CN101501064A Glycopeptide antibiotic derivative |
| 08/05/2009 | CN101501063A Polymyxin derivatives and uses thereof |
| 08/05/2009 | CN101501062A Novel biologically active peptides and their new uses |
| 08/05/2009 | CN101497656A Polypeptide with high combination activity with integrin alpha v beta 3 and use thereof |
| 08/05/2009 | CN101497655A Polypeptide hydration salt compound and use for anti-depression aspect |
| 08/05/2009 | CN101497654A Melanocortin receptor agonists |
| 08/05/2009 | CN101497653A Small peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 08/05/2009 | CN101497652A Peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 08/05/2009 | CN101497651A Compound with thrombus dissolving activity, as well as preparation and use thereof |
| 08/05/2009 | CN100522994C Discrimination between GnRH-I and GnRH-II |
| 08/05/2009 | CN100522993C Odorranagrahami antimicrobialpeptides and application thereof |
| 08/05/2009 | CN100522992C Novel ring-shape small-peptide BA and its use |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 08/04/2009 | US7569659 Admixture comprising a target molecule and a nucleic acid mimic comprising sterically bulky substituents |
| 08/04/2009 | US7569548 Method of preparing peptide |
| 08/04/2009 | US7569546 Apolipoprotein A1 mimetics and uses thereof |
| 08/04/2009 | US7569541 Malaria vaccine; cyclic peptidomimetics obtainable by these methods which are conformationally constrained due an internal cross-link between 4-aminoproline and glutamine, and having a central (Asn-Pro-Asn-Ala) |
| 08/04/2009 | US7569537 Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of Mycobacterium tuberculosis |
| 08/04/2009 | US7569231 adding delta -tocopherol to a mixture of anionic surfactant lipopeptide having a cyclic peptide structure and water and/or glycerin; polyoxyethyleneglyceryl ether fatty acid esters and polyoxyethylene sorbitol ether fatty acid esters; storage stability, preventing cosmetic separation of the composition |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2247009C Cryptic peptides and method for their identification |
| 07/30/2009 | WO2009094634A1 Lytic domain fusion constructs and methods of making and using same |
| 07/30/2009 | WO2009093692A1 Artificial peptide and use thereof |
| 07/30/2009 | WO2009092891A2 Modification of intrinsically disordered sequences for preparing vaccines |
| 07/30/2009 | WO2009092758A1 New blood coagulation factor inhibitors |
| 07/30/2009 | WO2009065949A3 Peptide production and purification process |
| 07/30/2009 | WO2008017734A8 Polymyxin derivatives and uses thereof |
| 07/30/2009 | WO2007110772A8 Immunomodulating oligopeptides |
| 07/30/2009 | US20090192289 Omi pdz modulators |
| 07/30/2009 | US20090192189 Treatment of cancers expressing p95 erbb2 |
| 07/30/2009 | US20090192107 Breast Cancer Markers |
| 07/30/2009 | US20090192092 Neuropeptides and Their Use for Pest Control |
| 07/30/2009 | US20090192091 Peptide inhibitors of protein kinase C |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090192083 Methods and compositions for the treatment of gastrointestinal disorders |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090191645 Compounds and methods for modulating integrin activity |
| 07/30/2009 | US20090191630 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 07/30/2009 | US20090191579 Analgesia with minimal tolerance and dependence by a mu opioid receptor agonist that also binds filamin a |
| 07/30/2009 | US20090191569 Mammalian Cytokines; Related Reagents |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191223 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 07/30/2009 | US20090191189 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/30/2009 | US20090191126 Peptide and multivalent peptide conjugate for diagnosis and treatment of vascular plaques |
| 07/30/2009 | US20090191123 Novel imaging agents |
| 07/30/2009 | DE10252284B4 Neue Cyclopeptide, ihre Verwendung, diese enthaltende Arznei-, akarizide und insektizide New cyclic peptides, their use, containing the same drug, acaricidal and insecticidal |
| 07/30/2009 | CA2713126A1 Lytic domain fusion constructs and methods of making and using same |
| 07/30/2009 | CA2713005A1 Difluorinated tripeptides as hcv serine protease inhibitors |
| 07/29/2009 | EP2082042A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/29/2009 | EP2081952A2 Peptides |
| 07/29/2009 | EP1761783B1 Identification of compounds modifying a cellular response |
| 07/29/2009 | EP1401473B1 Transporters comprising spaced arginine moieties |
| 07/29/2009 | CN101495502A N-terminally modified GLP-1 receptor modulators |
| 07/29/2009 | CN101495501A Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy |
| 07/29/2009 | CN101495500A Inhibition of alpha-synuclein aggregation |
| 07/29/2009 | CN101492495A A group of antigen epitope polypeptide and uses thereof |
| 07/28/2009 | US7566783 Long wavelength long lifetime luminophores |
| 07/28/2009 | US7566777 Genes encoding hormone and lytic peptides |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses |
| 07/28/2009 | US7566697 chemically ligating two oligopeptides, a first oligopeptide thioester having an acidic C-terminal amino acid, having a thioester group, a side chain, side chain protecting group( phenylacryl ester), prevents rearrangements between atoms of the side chain and thioester, with 2nd oligopeptide |
| 07/28/2009 | US7566695 Multimeric apoprotein agonists |
| 07/28/2009 | US7566444 Versatile hydrophilic dyes |
| 07/28/2009 | CA2178592C Long-acting injection suspensions and a process for their preparation |
| 07/23/2009 | WO2009092062A2 Fluorescent imaging agents |
| 07/23/2009 | WO2009090265A1 Method for identifying bplp and opiorphin agonists or antagonists |
| 07/23/2009 | WO2009090168A1 Anti-bacterial compositions |
| 07/23/2009 | WO2009089810A1 Production and use of antitumoral cyclodepsipeptides |
| 07/23/2009 | WO2009071276A3 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides |
| 07/23/2009 | WO2009027063A3 MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING β1-ADRENOCEPTOR ANTIBODIES |
| 07/23/2009 | WO2007145589A8 Peptides that are capable of binding to amyloid-beta peptide. |
| 07/23/2009 | WO2007133153A8 Improved antimicrobial peptides |
| 07/23/2009 | WO2007091958A8 Novel antimicrobial peptides and use thereof |
| 07/23/2009 | US20090187008 Adsorbent adsorbing antibody against beta 1 adrenoreceptor |
| 07/23/2009 | US20090186825 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186824 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/23/2009 | US20090186823 Synthetic arginine substituted peptides and their use |
| 07/23/2009 | US20090186422 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT |
| 07/23/2009 | US20090186043 Method and compositions for preventing and treating streptococcus pneumoniae infection |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | CA2749108A1 Fluorescent imaging agents |
| 07/23/2009 | CA2713423A1 Peptides and methods of use as therapeutics and screening agents |
| 07/23/2009 | CA2711972A1 Anti-bacterial compositions |